EcoDrugPlus

Presenilin 1

Ensembl ID : ENSCHOG00000010266
Gene Symbol: PSEN1
1 Cross references
202 Possible Orthologues:

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSCHOG00000001037
Gene Symbol: PSENEN
1 Cross references
185 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSCHOG00000007092
Gene Symbol: PGR
1 Cross references
194 Possible Orthologues:

Prostaglandin D2 Receptor

Ensembl ID : ENSCHOG00000003572
Gene Symbol: PTGDR
1 Cross references
118 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSCHOG00000002764
Gene Symbol: PTGER3
1 Cross references
196 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSCHOG00000010651
Gene Symbol: PTGFR
1 Cross references
195 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSCHOG00000005132
Gene Symbol: PTGS1
1 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSCHOG00000011857
Gene Symbol: PTGS2
1 Cross references
240 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSCHOG00000005395
Gene Symbol: PSMA1
1 Cross references
249 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSCHOG00000000644
Gene Symbol: PSMA2
1 Cross references
257 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSCHOG00000003395
Gene Symbol: PSMA3
1 Cross references
247 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSCHOG00000003419
Gene Symbol: PSMA4
1 Cross references
253 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).